Clinical Trial Tests Nivolumab for Patients with Rare Brain and Spine Cancers
This phase 2 clinical trial, led by Dr. Marta Penas-Prado, is for adults (age 18 or above) with rare brain and spine tumors. The goal is to test whether stimulating the immune system using the drug nivolumab can shrink these tumors or increase the time it takes for them to grow or spread.
Questions? Contact the NCI Neuro-Oncology Branch at (240) 760-6010 or [email protected].
Learn more about the trial: https://www.cancer.gov/research/parti...
Watch this video with audio descriptions: • Audio Described: Clinical Trial Tests...
Watch video Clinical Trial Tests Nivolumab for Patients with Rare Brain and Spine Cancers online without registration, duration hours minute second in high quality. This video was added by user National Cancer Institute 05 August 2024, don't forget to share it with your friends and acquaintances, it has been viewed on our site 1,362 once and liked it 9 people.